kotak-logo
Supreet Chemicals IPO

-- / --

Issue Date

--

Price Range

--

Lot Size

--

IPO Size

N/A

The 100% book building issue of Supreet Chemicals comprises a fresh issue aggregating up to ₹499 crores. There’s no offer for sale in this IPO. The total offer size of the issue aggregates up to ₹499 crores. The price band is [TBA] per share and the lot size is [TBA]. The IPO opens on [TBA] and closes on [TBA].

The listing date is on [TBA] and the allotment date is on [TBA]. The credit of shares to the Demat account will take place on [TBA], while the initiation of refund will take place on [TBA].

Supreet Chemicals is a specialty chemical intermediates manufacturer with expertise in handling complex chemistries and multi-step unit operations and processes. It’s one of the few specialty chemical intermediates companies which has competencies in handling complex reactions including more than 15 chemistries and up to 15 multi-step unit operations and processes, which enables it to cater to requirements of a wide range of end-products and applications.

The company proposes to utilise the IPO proceeds for:

  • Financing the capital expenditure requirements of the company towards the manufacturing facility
  • Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the company
  • General corporate purposes

The global chemicals market has grown from USD 4,005 Bn in CY2019 to USD 5,033Bn in CY2024, with a CAGR of 4.7%. Driven by rising demand for specialty chemicals and industrial growth in emerging markets, it is expected to grow with a CAGR of 5.4% to USD 6,543 Bn by CY2029.

Also, the global specialty chemical market stands at USD 1,309 billion in 2024 and is expected to reach USD 1,802 billion in 2029 at a CAGR of 6.6%. The past two decades have seen a significant shift in the specialty chemical intermediates industry, from developed countries (particularly the US) to emerging ones in the Asia-Pacific (APAC) region. The Asia Pacific (APAC) dominates the market across the world projected to grow at a CAGR of 6-7%, with a share of 56%, owing to the huge customer base, leading to high demand for specialty chemicals, increasing industrial production, and robust growth of the construction sector. APAC is followed by Europe and North America.

On the other hand, in terms of region-wise demand, India’s specialty chemical intermediates industry is expected to post 10.02% CAGR between 2025 and 2030, owing to rising demand from end-user industries, along with tight global supply on account of stringent environmental norms in China.

Supreet Chemicals is a specialty chemical intermediates manufacturer with expertise in handling complex chemistries and multi-step unit operations and processes. It’s one of the few specialty chemical intermediates companies which has competencies in handling complex reactions including more than 15 chemistries and up to 15 multi-step unit operations and processes, which enables it to cater to requirements of a wide range of end-products and applications.

The company’s products cater to end-use industries including textiles, pharmaceuticals, performance chemicals, personal care, agro-chemicals and others.

  • Expertise in handling complex chemistries and multi-step unit operations and processes
  • Extensive portfolio of differentiated products
  • Diversified end-use industries mitigating sector-specific downturns resulting in a de-risked business model
  • Diversified customer-base with long-standing customer relationships
  • Diversified domestic and global presence across geographies
  • Integrated manufacturing setup with a track-record of timely capacity additions
  • Experienced Promoters and professional management team
  • The company’s work with hazardous substances and complex processes exposes it to the possibility of accidents, which may harm people, property, and the environment, resulting in regulatory action
  • Any slowdown, temporary closure, or long-term shutdown of its manufacturing facilities may impact its ability to meet demand and deliver products on time
  • Adverse development affecting certain end-use industries could negatively impact business and results of operations.
  • Any restriction, delay or disruption to the timely and adequate procurement of raw materials, or volatility in the prices could adversely impact business
  • Investments in new products may not be successful and may be less profitable or may be loss-making
  • If products do not perform as expected or if competing products become available and gain wider market acceptance, its business may be adversely affected
  • Inability to diversify into new export markets may affect business and results of operations
  • Proposed expansion plans which involve setting up of a new greenfield manufacturing facility is subject to the risk of unanticipated delays in implementation and cost overruns
Loading chart...

Anchor Investor Bidding Date

TBA

IPO Registrar and Book Running Lead Manager

  • Registrar: MUFG Intime India Pvt
  • Book Running Lead Manager: IIFL Capital Services

The business of Supreet Chemicals is categorised into product families, namely (a) Aromatic Amines and Sulphonamides which include benzene derivative products; (b) Amino Phenols which include phenol derivative products; and (c) Other Specialties. It expanded its commercialised product portfolio from 102 products in Fiscal 2023 to 135 products in Fiscal 2025.

The revenue from operations of Supreet Chemicals grew from ₹312.741 crores in FY 23 to ₹362.547 crores in FY 25. The company has consistently enhanced its competencies and its commercialised product portfolio which has expanded from 102 products in Fiscal 2023 to 135 products in Fiscal 2025.

Also, its products of up to five multi-step unit operations and processes have increased from 61 in Fiscal 2023 to 74 in Fiscal 2025 and products with six to 15 multi-step unit operations and processes have increased from 41 in Fiscal 2023 to 61 in Fiscal 2025. Its expertise in handling complex chemistries and extensive portfolio of differentiated products has helped the company grow over the years.

As of March 31, 2025, Supreet Chemicals supplied its products to 188 customers in India and 27 customers globally in 14 countries including Thailand, China and Mexico. While China, Mexico and Thailand comprised the majority of its revenue from exports, contributing to 17.68%, 20.41% and 19.10% over the Fiscal 2025, Fiscal 2024 and Fiscal 2023.

It has seen increasing revenues from other countries across geographies, including Indonesia, Canada, Switzerland, Taiwan, Japan, South Korea, Germany, Czech Republic. Hong Kong, Spain and the USA.

1. Visit the Registrar’s Website

  • Visit the website of MUFG Intime India Pvt
  • Choose ‘Public Issues’ from Investor Services dropdown
  • Choose the name of the company from ‘Select Company’ dropdown
  • Enter any of these - PAN Number, Application Number, DP/Client ID, Account Number / IFSC
  • Click on Submit to check the status

2. Verify on the National Stock Exchange Website

The National Stock Exchange (NSE) has an IPO Bid Verification module. You can use it to check the status of Supreet Chemicals IPO. Go to the NSE website and find the 'Invest' tab. Click on 'Verify IPO Bids' under 'Resources & Tools'.

On the NSE IPO Bid Verification page, enter:

  • Company name from dropdown
  • Application number
  • PAN

Then click 'Submit' to know the allotment status.

3. Check on the Bombay Stock Exchange Website

  • Go to the BSE website
  • Click on ‘Status of Issue Application’ under ‘Investor Services’
  • Click on ‘Application Status Check’
  • Choose the ‘Issue Type’ and ‘Issue Name’
  • Enter either your PAN or Application Number
  • Tick the box ‘I’m not a robot’
  • Click on ‘Search to view allotment status
  • Log in to your Kotak Neo Demat account - Log in to your Demat account to access IPO investments. Next, select the current IPO section.
  • Specify IPO details - Enter the number of lots and the price you wish to apply for.
  • Enter UPI ID - After entering your UPI ID, click submit. This will place your bid with the exchange.
  • Mandate Notification - Your UPI app will receive a mandate notification to block funds.
  • Approve Request - Your funds will be blocked once you approve the mandate request on your UPI.

The Supreet Chemicals IPO opens for subscription from [-] to [-], with a total issue size of [-]. The IPO price band is ₹[-] per share with a lot size of [-]. The company aims to list the shares on BSE & NSE on [-].

The Supreet Chemicals IPO will open for subscription on [-] and will close on [-] for investors.

The minimum lot size for the Supreet Chemicals IPO is [-] equity shares, requiring a minimum investment of ₹[-] for retail investors applying in the IPO.

The price band of the Supreet Chemicals IPO has been fixed at ₹[-] per equity share.

You can apply for the Supreet Chemicals IPO online through the Kotak Neo Website or the Kotak Neo App using UPI or ASBA during the IPO subscription period.

Supreet Chemicals IPO allotment will take place on [-].

You can check the Supreet Chemicals IPO allotment status online on the registrar’s website or on the NSE and BSE IPO allotment pages using your application number, PAN, or demat account details.

Supreet Chemicals shares will list on the stock exchanges on [-].

The exact dates of the IPO are yet to be announced.

Manjeetsingh Gurbirsingh Sarna is the MD of Supreet Chemicals .

The lot size of shares in the Supreet Chemicals IPO is [TBA].

You can read more about the IPO of Supreet Chemicals from the company’s draft red herring prospectus here.

This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Neo Research Team, nor is it a report published by the Kotak Neo Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.